Medical Digest & Congress Report

Professor Annette H. M. van der Helm van Mil share her thoughts about EULAR Recommendations on risk stratification in patients with arthralgia suspicious for progression to Rheumatoid Arthritis.

Video: https://medicaldigest.org/scientific-contents/interview:update-eularacr-project-risk-stratification-patients-arthralgia-suspicious-progression-ra

Professor Anja Strangfeld chaired an important session during EULAR 2024 on cardiovascular comorbidities of Rheumatic and Musculoskeletal Diseases and their management.

Video: https://medicaldigest.org/scientific-contents/interview:cardiovascular-comorbidities-rheumatic-and-musculoskeletal-diseases

Professor Rene Westhovens chaired an interesting session during EULAR 2024, where participants learned to recognise the range of pain and fatigue manifestations and impact in Rheumatic and Musculoskeletal Diseases and heared about options for managing different pain mechanisms in RMDs. State of the art and risks of opioid use are discussed and the role of self-management approaches to manage pain and fatigue and reduce opioid use are presented.

Video: https://medicaldigest.org/scientific-contents/interview:fatigue-pain-and-opioids-rheumatological-diseases

Professor Mariano Andrés on the long-term consequences of asymptomatic urate deposition in the joint.

Video: https://medicaldigest.org/scientific-contents/interview:asymptomatic-ultrasonographic-urate-deposition-joint-are-there-long-term-consequences

Professor Michael Nurmohamed shares his experiences on cardiovascular comorbidities of Rheumatic and Musculoskeletal Diseases and their management, as well as new findings such as the results of the ORAL Surveillance study.

Video: https://medicaldigest.org/scientific-contents/interview:cardiovascular-risk-rheumatic-musculoskeletal-disease

Professor Francisca Sivera chaired an informative session during EULAR 2024, on the long-term consequences of asymptomatic urate deposition in the joint, critically appraise the evidence regarding urate-lowering therapy for renal disease and discern the extent to which hyperuricemia contributes to cardiovascular disease.

Video: https://medicaldigest.org/scientific-contents/interview:asymptomatic-hyperuricemia-innocent-bystander-or-menacing-foe

Professor Raphael Micheroli chaired an exciting session during EULAR 2024, an update on the results of RA prevention trials to date, describe the lessons learnt from these RCTs.

Video: https://medicaldigest.org/scientific-contents/interview:rheumatoid-arthritis-prevention-what-have-we-learnt-and-where-do-we-go-next

Professor Valentina Pucino chaired an interesting session during EULAR 2024 on critical metabolic pathways and the interplay between metabolism and immune responses.

Video: https://medicaldigest.org/scientific-contents/interview:metabolic-reprogramming-autoimmunity

We asked Professor Kausik Ray, President of the European Atherosclerosis Society about 2024 EAS Congress and the Society, as well as the Joint Sessions and the Anitschkow Lecture.

Video: https://medicaldigest.org/scientific-contents/interview:overview-2024-eas-congress

Professor Gianfranco Parati share his thoughts on combination of a beta-blocker with calcium channel blocker in hypertension.

Video: https://medicaldigest.org/scientific-contents/interview:combination-beta-blocker-calcium-channel-blocker-hypertension